Heo, Sung-Koun Cho, Jeiwon Cheon, Ji-Woong Choi, Min-Koo Im, Dong-Soon Kim, Jung Ju Choi, Yang Gyu Jeon, Do Yong Chung, Suk-Jae Shim, Chang-Koo Kim, Dae-Duk 2024-01-21T00:02:11Z 2024-01-21T00:02:11Z 2021-09-03 2008-01 0142-2782 https://pubs.kist.re.kr/handle/201004/133843 Ketoprofen plasters of 70cm(2) size using DuroTak(R) acrylic adhesive polymers were developed either containing 30mg (Ketotop-L) or 60mg drug (Ketotop-P). The in vitro skin permeation profile was obtained in hairless mouse skin and showed the permeation rate of Ketotop-P to be twice that of Ketotop-L. The plasma concentration profile of ketoprofen was determined in Sprague-Dawley rats after applying a 3x3cm(2) plaster. AUCO-24h and C, of Ketotop-P were 260.92 mu g.h/ml and 25.09 mu g/ml, respectively, which were about twice the values of Ketotop-L. The hind paw edema induced by carrageenan injection was measured for 6h after applying a 2 x 2 cm 2 plaster, and the area under the time-response curve (AUR) value was significantly lower in Ketotop-P attached rats (180.70% . h) than in those with the Ketotop-L (298.65% . h) and the control (407.04% . h) groups, indicating a stronger anti-inflammatory action of Ketotop-P. However, the analgesic effect of the two formulations did not show a statistically significant difference. In conclusion, Ketotop-P was able to achieve higher plasma concentration of ketoprofen, thereby exhibiting higher and more constant anti-inflammatory effect compared with Ketotop-L. Copyright (C) 2007 John Wiley & Sons, Ltd. English WILEY PLASMA ABSORPTION NSAIDS Pharmacokinetics and pharmacodynamics of ketoprofen plasters Article 10.1002/bdd.587 1 BIOPHARMACEUTICS & DRUG DISPOSITION, v.29, no.1, pp.37 - 44 BIOPHARMACEUTICS & DRUG DISPOSITION 29 1 37 44 scie scopus 000253332800005 2-s2.0-39449116361 Pharmacology & Pharmacy Pharmacology & Pharmacy Article PLASMA ABSORPTION NSAIDS ketoprofen plaster pharmacokinetics pharmacodynamics anti-inflammation analgesic